Epithelial-Mesenchymal Transition and Breast Cancer

Journal of Clinical Medicine
Yanyuan WuJaydutt V Vadgama

Abstract

Breast cancer is the most common cancer in women and distant site metastasis is the main cause of death in breast cancer patients. There is increasing evidence supporting the role of epithelial-mesenchymal transition (EMT) in tumor cell progression, invasion, and metastasis. During the process of EMT, epithelial cancer cells acquire molecular alternations that facilitate the loss of epithelial features and gain of mesenchymal phenotype. Such transformation promotes cancer cell migration and invasion. Moreover, emerging evidence suggests that EMT is associated with the increased enrichment of cancer stem-like cells (CSCs) and these CSCs display mesenchymal characteristics that are resistant to chemotherapy and target therapy. However, the clinical relevance of EMT in human cancer is still under debate. This review will provide an overview of current evidence of EMT from studies using clinical human breast cancer tissues and its associated challenges.

References

Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·K YoshiuraS Hirohashi
Aug 30, 2000·Nature·C M PerouD Botstein
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L VogelMichael Press
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Aug 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Christos SotiriouEdison T Liu
May 22, 2004·Annals of the New York Academy of Sciences·Rachel B HazanKimita Suyama
Nov 19, 2004·Neoplasia : an International Journal for Oncology Research·Lu XieHarold L Moses
Aug 5, 2005·International Journal of Cancer. Journal International Du Cancer·Stephen HiscoxRobert I Nicholson
Oct 11, 2005·Annual Review of Cell and Developmental Biology·Xin-Hua Feng, Rik Derynck
Sep 28, 2006·Annual Review of Medicine·Piero DalerbaMichael F Clarke
Oct 31, 2006·Nature Cell Biology·Jong In YookStephen J Weiss
May 18, 2007·Nature Reviews. Cancer·Héctor PeinadoAmparo Cano
Feb 19, 2008·Cancer Research·David SarrióJosé Palacios
Apr 2, 2008·Cancer Chemotherapy and Pharmacology·E MontagnaM De Laurentiis
May 8, 2008·Clinical & Experimental Metastasis·T BlickE W Thompson
Jun 5, 2008·Cell Stem Cell·Derek C Radisky, Mark A LaBarge
Jun 19, 2008·Breast Cancer Research : BCR·Gabriella HonethCecilia Hegardt
Sep 2, 2008·Nature Cell Biology·Alessandro SorrentinoMaréne Landström
Oct 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fadi BraitehRazelle Kurzrock
Oct 17, 2008·Molecular Cell·Motozo YamashitaYing E Zhang
Jan 30, 2009·Cell Cycle·Amaia Lujambio, Manel Esteller
Apr 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Qing-Quan LiZu-De Xu
Apr 22, 2009·BMC Genomics·Alessandro GuffantiGianluca De Bellis
Jun 3, 2009·The Journal of Clinical Investigation·Hervé AcloqueM Angela Nieto
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jean-Pierre J Issa, Hagop M Kantarjian

❮ Previous
Next ❯

Citations

Oct 6, 2016·International Journal of Molecular Sciences·Zhaomei MuMassimo Cristofanilli
Feb 18, 2017·Histopathology·David J ByrneStephen B Fox
Mar 8, 2017·Journal of Cellular Biochemistry·Steven M MooneyBrendan J McConkey
Apr 6, 2017·Endocrinology·Ramadevi SubramaniRajkumar Lakshmanaswamy
Feb 15, 2017·Veterinary and Comparative Oncology·M Milovancev, D S Russell
Feb 15, 2018·Cancer Biomarkers : Section a of Disease Markers·Jinfang XueYanan Wang
Nov 16, 2018·Molecular Oncology·Christiane KlecMartin Pichler
Sep 13, 2018·Journal of Cellular Biochemistry·Deepa SrinivasanMeenakshi A Chellaiah
Nov 6, 2018·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Jun NakanishiTakuji Nakashima
Apr 18, 2019·Development·Vanesa Jiménez-Amilburu, Didier Y R Stainier
Nov 7, 2019·Journal of Experimental & Clinical Cancer Research : CR·Linling LinZekuan Xu
Jan 13, 2018·Genes & Cancer·Anjali GeethadeviPradeep Chaluvally-Raghavan
Mar 24, 2018·Cellular Oncology (Dordrecht)·Meysam YousefiAlihossein Saberi
Jun 22, 2018·Pflügers Archiv : European journal of physiology·Adina VulturIvan Bogeski
Jan 11, 2019·Contrast Media & Molecular Imaging·Manuel ScimecaElena Bonanno
Oct 12, 2019·Experimental and Therapeutic Medicine·Yuxia DuanLing Zhang
Jun 24, 2018·Scientific Reports·Puja KhannaGyeong Hun Baeg
Mar 9, 2019·Breast Cancer Research : BCR·Geraldine Vidhya VijaySendurai A Mani
Mar 10, 2020·Journal of Oncology·Sierra A Colavito
Dec 13, 2019·Journal of Experimental & Clinical Cancer Research : CR·Yongjun LuoWeihua Cai

❮ Previous
Next ❯

Methods Mentioned

BETA
FACS
ubiquitination
imaging techniques

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.